Abstract:The cat eye syndrome chromosome region candidate 2 (CECR2) protein is an epigenetic regulator involved in chromatin remodeling and transcriptional control. The CECR2 bromodomain (CECR2-BRD) plays a pivotal role in directing the activity of CECR2 through its capacity to recognize and bind acetylated lysine residues on histone proteins. This study elucidates the binding specificity and structural mechanisms of CECR2-BRD interactions with both histone and non-histone ligands, employing techniques such as isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy, and a high-throughput peptide assay. The CECR2-BRD selectively binds acetylated histone H3 and H4 ligands, exhibiting a preference for multi-acetylated over mono-acetylated targets. The highest affinity was observed for tetra-acetylated histone H4. Neighboring post-translational modifications, including methylation and phosphorylation, modulate acetyllysine recognition, with significant effects observed for histone H3 ligands. Additionally, this study explored the interaction of the CECR2-BRD with the acetylated RelA subunit of NF-κB, a pivotal transcription factor in inflammatory signaling. Dysregulated NF-kappaB signaling is implicated in numerous pathologies, including cancer progression, with acetylation of RelA at lysine 310 (K310ac) being critical for its transcriptional activity. Recent evidence linking the CECR2-BRD to RelA suggests it plays a role in inflammatory and metastatic pathways, underscoring the need to understand the molecular basis of this interaction. We found the CECR2-BRD binds to acetylated RelA with micromolar affinity, and uses a distinctive binding mode to recognize this non-histone ligand. These results provide new insight on the role of CECR2 in regulating NF-κB-mediated inflammatory pathways. Functional mutagenesis of critical residues, such as Asn514 and Asp464, highlight their roles in ligand specificity and binding dynamics. Notably, the CECR2-BRD remained monomeric in solution and exhibited differential conformational responses upon ligand binding, suggesting adaptive recognition mechanisms. Furthermore, the CECR2-BRD exclusively interacts with nucleosome substrates containing multi-acetylated histones, emphasizing its role in transcriptional activation within euchromatic regions. These findings position the CECR2-BRD as a key chromatin reader and a promising therapeutic target for modulating transcriptional and inflammatory processes, particularly through the development of selective bromodomain inhibitors.

Does bromodomain flexibility influence histone recognition?

Protein dynamics and structural waters in bromodomains

Discovery of a hidden transient state in all bromodomain families

A histone-mimicking interdomain linker in a multidomain protein modulates multivalent histone binding

Solution Structure of Human Brg1 Bromodomain and Its Specific Binding to Acetylated Histone Tails.

A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT

Structural insight into the recognition of acetylated histone H3K56ac mediated by the bromodomain of CREB‐binding protein

Structural insight into CBP bromodomain-mediated recognition of acetylated histone H3K56ac.

Dynamics Simulation On The Flexibility And Backbone Motions Of Hp1 Chromodomain Bound To Free And Lysine 9-Methylated Histone H3 Tails

Targeting bromodomains: epigenetic readers of lysine acetylation

3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands

Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains

Structural Basis and Binding Properties of the Second Bromodomain of Brd4 with Acetylated Histone Tails.

Bromodomains regulate dynamic targeting of the PBAF chromatin-remodeling complex to chromatin hubs

Metabolically controlled histone H4K5 acylation/acetylation ratio drives BRD4 genomic distribution

The CECR2 bromodomain displays distinct binding modes to select for acetylated histone proteins versus non-histone ligands.

Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation.

Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain

Family-wide Characterization of Histone Binding Abilities of Human CW Domain-containing Proteins

A Chemical Toolbox for the Study of Bromodomains and Epigenetic Signaling

The TRIM33 Bromodomain Recognizes Histone Lysine Lactylation